Cargando…
Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma
BACKGROUND: The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249769/ https://www.ncbi.nlm.nih.gov/pubmed/25103784 http://dx.doi.org/10.1186/1477-7819-12-253 |
_version_ | 1782346885641535488 |
---|---|
author | Ishikawa, Masashi Sonobe, Makoto Imamura, Naoto Sowa, Terumasa Shikuma, Kei Date, Hiroshi |
author_facet | Ishikawa, Masashi Sonobe, Makoto Imamura, Naoto Sowa, Terumasa Shikuma, Kei Date, Hiroshi |
author_sort | Ishikawa, Masashi |
collection | PubMed |
description | BACKGROUND: The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospectively evaluated the expression of the GLI family of genes in advanced stage lung adenocarcinoma samples and determined their relation to patient survival. METHODS: The levels of GLI1, GLI2, and GLI3 mRNA expression were measured by quantitative real-time polymerase chain reaction in surgically obtained tissue samples from stage II-IV lung adenocarcinoma patients (n = 102). Pairwise comparisons between all three GLI mRNA expression were performed, and after dichotomizing the patients into low and high expression groups according to each GLI mRNA expression level, survival curves were calculated and multivariate analyses were conducted. RESULTS: Significant positive correlation was found between GLI1 and GLI3 mRNA expression (P <0.001). Tumors with higher expression (upper 15%) of GLI1 or GLI3 mRNA were associated with poor survival in stage II-IV (5-year overall survival rates: GLI1 mRNA low, 41.7% vs. high, 20.0%, P = 0.0074; GLI3 mRNA low, 43.1% vs. high, 13.3%, P = 0.0062) and stage III-IV (5-year overall survival rates: GLI1 mRNA low, 34.0% vs. high, 0%, P = 0.0012; GLI3 mRNA low, 33.4% vs. high, 7.7%, P = 0.057) lung adenocarcinoma patients. GLI2 mRNA expression did not appear to have great clinical significance. Multivariate analysis revealed higher GLI1 mRNA expression as an independent factor for unfavorable patient survival (P = 0.0030, hazard ratio = 3.1, 95% confidence interval = 1.5-6.2), as well as tumor differentiation and stage. CONCLUSIONS: Expression of GLI1 and GLI3 mRNA was strongly correlated, and their overexpression, especially that of GLI1, was found to be predictive of aggressive tumor behavior. This study indicates that the Hh pathway may be a key oncogenic signaling network in tumor pathogenesis and, thus, a potential therapeutic target in advanced lung adenocarcinoma. |
format | Online Article Text |
id | pubmed-4249769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42497692014-12-02 Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma Ishikawa, Masashi Sonobe, Makoto Imamura, Naoto Sowa, Terumasa Shikuma, Kei Date, Hiroshi World J Surg Oncol Research BACKGROUND: The hedgehog (Hh) signaling pathway is aberrantly activated in various cancers. Expression of the GLI family of genes, which encode for transcriptional factors of the Hh pathway, has not been fully assessed in clinical samples of advanced lung adenocarcinoma. In this study, we retrospectively evaluated the expression of the GLI family of genes in advanced stage lung adenocarcinoma samples and determined their relation to patient survival. METHODS: The levels of GLI1, GLI2, and GLI3 mRNA expression were measured by quantitative real-time polymerase chain reaction in surgically obtained tissue samples from stage II-IV lung adenocarcinoma patients (n = 102). Pairwise comparisons between all three GLI mRNA expression were performed, and after dichotomizing the patients into low and high expression groups according to each GLI mRNA expression level, survival curves were calculated and multivariate analyses were conducted. RESULTS: Significant positive correlation was found between GLI1 and GLI3 mRNA expression (P <0.001). Tumors with higher expression (upper 15%) of GLI1 or GLI3 mRNA were associated with poor survival in stage II-IV (5-year overall survival rates: GLI1 mRNA low, 41.7% vs. high, 20.0%, P = 0.0074; GLI3 mRNA low, 43.1% vs. high, 13.3%, P = 0.0062) and stage III-IV (5-year overall survival rates: GLI1 mRNA low, 34.0% vs. high, 0%, P = 0.0012; GLI3 mRNA low, 33.4% vs. high, 7.7%, P = 0.057) lung adenocarcinoma patients. GLI2 mRNA expression did not appear to have great clinical significance. Multivariate analysis revealed higher GLI1 mRNA expression as an independent factor for unfavorable patient survival (P = 0.0030, hazard ratio = 3.1, 95% confidence interval = 1.5-6.2), as well as tumor differentiation and stage. CONCLUSIONS: Expression of GLI1 and GLI3 mRNA was strongly correlated, and their overexpression, especially that of GLI1, was found to be predictive of aggressive tumor behavior. This study indicates that the Hh pathway may be a key oncogenic signaling network in tumor pathogenesis and, thus, a potential therapeutic target in advanced lung adenocarcinoma. BioMed Central 2014-08-08 /pmc/articles/PMC4249769/ /pubmed/25103784 http://dx.doi.org/10.1186/1477-7819-12-253 Text en © Ishikawa et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Ishikawa, Masashi Sonobe, Makoto Imamura, Naoto Sowa, Terumasa Shikuma, Kei Date, Hiroshi Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma |
title | Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma |
title_full | Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma |
title_fullStr | Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma |
title_full_unstemmed | Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma |
title_short | Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma |
title_sort | expression of the gli family genes is associated with tumor progression in advanced lung adenocarcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249769/ https://www.ncbi.nlm.nih.gov/pubmed/25103784 http://dx.doi.org/10.1186/1477-7819-12-253 |
work_keys_str_mv | AT ishikawamasashi expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma AT sonobemakoto expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma AT imamuranaoto expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma AT sowaterumasa expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma AT shikumakei expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma AT datehiroshi expressionoftheglifamilygenesisassociatedwithtumorprogressioninadvancedlungadenocarcinoma |